What is the proper dosage of Banophen (diphenhydramine) for relieving allergic symptoms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Banophen (Diphenhydramine) Dosing for Allergic Symptoms

For adults and children over 12 years, administer 25-50 mg orally every 4-6 hours, not exceeding 6 doses in 24 hours; for children 6 to under 12 years, give 25 mg (10 mL) every 4-6 hours; diphenhydramine is not recommended for children under 6 years of age for over-the-counter use. 1

Adult Dosing

  • Oral administration: 25-50 mg every 4-6 hours as needed, with a maximum of 6 doses per 24-hour period 1
  • Intravenous administration: 25-50 mg when used as an adjunct in medical procedures, with onset of action within several minutes and duration of 4-6 hours 2
  • The drug distributes quickly throughout the body, including the central nervous system 2

Pediatric Dosing

  • Children 6 to under 12 years: 25 mg (10 mL of oral solution) every 4-6 hours, not exceeding 6 doses in 24 hours 1
  • Children under 6 years: Do not use for over-the-counter allergic symptom relief 1
  • For prevention of drug-induced akathisia in children: 1-2 mg/kg per dose (maximum 50 mg) administered parenterally 3

Important Clinical Considerations

Pharmacokinetics

  • Onset of action occurs within several minutes when given intravenously 2
  • Duration of effect is 4-6 hours 2
  • The sedative effect is enhanced when combined with alcohol or other CNS depressants such as benzodiazepines or opioid narcotics 2

Common Adverse Effects

  • Hypotension, dizziness, blurred vision, dry mouth, epigastric discomfort, urinary retention, and wheezing 2
  • Sedation and cognitive/psychomotor impairment are recognized side effects that may decrease awareness of symptoms 2
  • Excessive sedation can occur, particularly when combined with other sedating medications 3

Critical Safety Warnings

Toxicity Thresholds

  • Children under 6 years: Ingestions of ≥7.5 mg/kg require emergency department evaluation 4
  • Patients 6 years and older: Ingestions of ≥7.5 mg/kg or 300 mg (whichever is less) require emergency department evaluation 4
  • Toxic doses can cause loss of consciousness, seizures, QRS widening, agitation, hallucinations, and respiratory depression 4

Special Precautions

  • Topical diphenhydramine can be absorbed systemically and has resulted in fatal toxicity in children 5
  • Rapid intravenous administration or excessive doses can cause clinically significant and potentially life-threatening adverse effects 6
  • Monitor for dystonic reactions when used with medications like prochlorperazine or metoclopramide 2

Role in Anaphylaxis Management

  • Diphenhydramine is considered adjunctive therapy only for anaphylaxis and should never substitute for epinephrine 2
  • Useful only for relieving itching and urticaria; does not relieve stridor, shortness of breath, wheezing, gastrointestinal symptoms, or shock 2
  • First-generation H1 antihistamines like diphenhydramine 25-50 mg can be given orally or intravenously as adjunctive treatment 2
  • Alternative dosing with less-sedating second-generation antihistamines (such as cetirizine 10 mg) may be preferred due to faster onset and reduced sedation 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diphenhydramine Dosing for Prevention of Prochlorperazine-Induced Akathisia in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Death of a child from topical diphenhydramine.

The American journal of forensic medicine and pathology, 2009

Research

Diphenhydramine: A Review of Its Clinical Applications and Potential Adverse Effect Profile.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.